XTL Biopharmaceutica (Israel) Financial Diagnostics

XTLB -- Israel Stock  

ILS 8.30  2.60  23.85%

XTL Biopharmaceuticals Ltd diagnostics interface makes it easy to digest most current publicly released information about XTL Biopharmaceutica as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis XTL Biopharmaceutica price relationship with some important fundamental indicators such as market cap and management efficiency.

XTL Biopharmaceutica Note

The company had not issued any dividends in recent years. XTL Biopharmaceuticals Ltd., a biopharmaceutical company, engages in the acquisition and development of pharmaceutical products for the treatment of autoimmune diseases. XTL Biopharmaceuticals Ltd. was founded in 1993 and is headquartered in Raanana, Israel. XTL Biopharmaceutica is traded on Tel Aviv Stock Exchange in Israel. For more information please call the company at 972 9 955 7080 or visit http://www.xtlbio.com.

XTL Biopharmaceuticals Alerts

XTL Biopharmaceutica appears to be very risky and stock price may revert if volatility continues
XTL Biopharmaceutica has high likelihood to experience some financial distress in the next 2 years
XTL BIOPHARMAC has accumulated about 5.54 M in cash with (1.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.

Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 33.94 M.

Management Efficiency

XTL Biopharmaceuticals Ltd has return on total asset (ROA) of (9.81) % which means that it has lost $9.81 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of 22.08 % meaning that it generated $22.08 on every $100 dollars invested by stockholders.

Technical Drivers

XTL Biopharmaceuticals Ltd maintains Risk Adjusted Performance of 0.309 and Mean Deviation of 5.07. In relation to Fundamental Indicators, Macroaxis technical analysis interface lets you check available technical drivers of XTL Biopharmaceuticals Ltd as well as the relationship between them. Specifically you can use this information to find out if the organization will indeed mirror its model of past data patterns or the prices will eventually revert. We found nineteen technical drivers for XTL Biopharmaceuticals which can be compared to its rivals. Please check out XTL Biopharmaceuticals Information Ratio, Treynor Ratio, Value At Risk, as well as the relationship between Jensen Alpha and Maximum Drawdown to decide if XTL Biopharmaceuticals is priced some-what accurately providing market reflects its latest price of 8.3 per share.

XTL Biopharmaceuticals Price Movement Analysis

Time Period
Deviations up
Deviations down
MA Type
  Portfolio Suggestion    
Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. XTL Biopharmaceutica middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for XTL Biopharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target. View also all equity analysis or get more info about bollinger bands overlap studies indicator.

XTL Biopharmaceutica Technical and Predictive Indicators

XTL Biopharmaceutica Forecast Models

Did you try this?

Run Correlation Analysis Now


Correlation Analysis

Reduce portfolio risk simply by holding instruments which are not perfectly correlated
All  Next Launch Correlation Analysis

Also Currentnly Active

Purchased over 90 shares of
a day ago
Traded for 26.13
Purchased over 90 shares of
a day ago
Traded for 80.82
Purchased over 90 shares of
a day ago
Traded for 42.67
See also Your Current Watchlist. Please also try Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Search macroaxis.com